Serotonin syndrome after administration of milnacipran for fibromyalgia.
Yacoub
Hussam A
HA
UMDNJ-New Jersey Medical School, 90 Bergen Street, DOC 8100, Newark, NJ 07103, USA.
Johnson
William G
WG
Souayah
Nizar
N
D000368:Aged; D003521:Cyclopropanes / Q000009:adverse effects*; D003533:Cyproheptadine / Q000627:therapeutic use*; D005356:Fibromyalgia / Q000188:drug therapy*; D006801:Humans; D008297:Male; D000078764:Milnacipran; D012702:Serotonin Antagonists / Q000627:therapeutic use; D020230:Serotonin Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects
D003521:Cyclopropanes; D003533:Cyproheptadine; D000078764:Milnacipran; D012702:Serotonin Antagonists; D017367:Selective Serotonin Reuptake Inhibitors